CVS - CVS Health Corporation
| Previous Close | 80.34 |
| Open | 80.96 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 80.13 - 81.56 |
| 52 Week Range | 60.14 - 83.88 |
| Volume | 6,657,453 |
| Avg. Volume | 7,355,446 |
| Market Cap | 82.319B |
| Beta (3Y Monthly) | 1.00 |
| PE Ratio (TTM) | 27.51 |
| EPS (TTM) | 2.94 |
| Earnings Date | Feb 6, 2019 - Feb 11, 2019 |
| Forward Dividend & Yield | 2.00 (2.51%) |
| Ex-Dividend Date | 2018-10-23 |
| 1y Target Est | 92.32 |
- CNBC Videos•6 days ago
There will be increased awareness of how much innovation ...
John Sculley, RX Advance chairman and former CEO of Apple, joins 'Squawk Alley' to discuss how the healthcare industry is going to change following the midterm elections.
- ACCESSWIRE•17 hours ago
4 Healthcare Stocks Investors Are Watching In November
Eighty-three percent of healthcare organizations responding to an American Telemedicine Association* poll said they are highly likely to invest in telehealth with operational efficiency and convenience in mind. Of the 171 healthcare executives participating in the annual ATA Executive Leadership Survey, 88% of those who are likely to purchase telehealth tools are planning to do so. "This executive leadership survey confirms undeniably today's leaders view telemedicine as a major driver in transforming healthcare," said Jonathan Linkous, CEO, American Telemedicine Association.
Reuters•18 hours agoWalmart, Home Depot adopt health insurer tactic in drug copay battle
Walmart (WMT.N) and Home Depot (HD.N), two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards for everything from multiple sclerosis treatments to widely-used rheumatoid arthritis medications sold through a specialty pharmacy.
Markit•18 hours agoSee what the IHS Markit Score report has to say about CVS Health Corp.
CVS Health Corp NYSE:CVS
- Zacks•yesterday
CVS Health (CVS) Gains As Market Dips: What You Should Know
CVS Health (CVS) closed at $80.34 in the latest trading session, marking a +0.64% move from the prior day.
- InvestorPlace•yesterday
5 Stocks to Sell After the Midterm Election
After Democrats obtained a narrow majority in the House of Representatives in the midterm elections, both House Democrats and President Trump will likely be looking to make at least some deals. To retain their majority, House Democrats will have to convince moderate voters in the swing districts that Democrats narrowly won that they are moderate and can be productive. For his part, President Trump will likely have to convince at least some moderate voters, i.e., centrist suburban women and independents that he can make deals that will make the country and their lives better.
- Bloomberg•2 days ago
Your Private Data Is Quietly Leaking Online, Thanks to a Basic Web Security Error
The personal information of American charity donors, political party supporters, and online shoppers, has continued to quietly leak onto the internet as a result of poor website security practices, new research shows. As many as one in five e-commerce sites in the U.S. are still leaving their customers exposed, Philadelphia-based search marketing company Seer Interactive said Monday. "If you were one of the 50 largest e-commerce sites you’d think you’d have this under wraps, and that’s the most troubling thing," said Adam Melson, a director at Seer.
- Kiplinger•2 days ago
10 Best Value Stocks to Buy Now
Value stocks are en vogue again. As recently as the end of May, stock prognosticators were calling for the Dow Jones Industrial Average to hit 30,000. Some suggested the Dow would reach that number by the end of 2018. Growth looked in, and slow-but-steady value picks were out. That was until October's bout of nauseating volatility. Thanks to a trade war with China, higher interest rates, problematic technology earnings and worries that a decade-long bull market is primed to lose its legs, the Nasdaq hit correction mode and the Standard & Poor's 500-stock index came close. Growth stocks - especially smaller companies - have been hammered, while large-cap value stocks have gained favor among investors looking for a little protection to go with their upside potential. Here are 10 large value stocks to buy now, with the expectation that they should thrive compared to their growthy brethren in a tumultuous environment. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond
Markit•4 days agoSee what the IHS Markit Score report has to say about CVS Health Corp.
CVS Health Corp NYSE:CVS
- ACCESSWIRE•5 days ago
Healthcare Stocks Shift Focus To eHealth Growth Trends; Premier Health Group, Inc. (PHGRF) (PHGI), CVS Health, Allscripts
With this in mind, a number of public companies are getting actively involved in capturing early market share including Premier Health Group, Inc. (PHGRF) (PHGI), CVS Health (CVS) and Allscripts (MDRX). Premier Health Group, Inc. (PHGRF) (PHGI) entered the primary care clinic and healthcare technology business via the HealthVue transaction. Premier obtained access to a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.
- Investor's Business Daily•8 days ago
CVS Health Earnings Top Estimates But No Boost To Outlook
In the last CVS Health earnings report before its Aetna takeover closes, the drugstore and pharmacy benefit manager giant edged past views. CVS stock rose.
- Investor's Business Daily•6 days ago
Humana Hits Buy Point On Earnings; Election Results Send Health Insurers Soaring
Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.
- Thomson Reuters StreetEvents•6 days ago
Edited Transcript of CVS earnings conference call or presentation 6-Nov-18 1:30pm GMT
Q3 2018 CVS Health Corp Earnings Call
Market Realist•6 days agoCVS: Analysts’ Ratings and Target Prices
CVS Health (CVS) posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock. RBC increased its target price to $100 per share on CVS from $99. Meanwhile, Baird raised the target price to $77 from $73. Analysts have a consensus target price of $89.55 per share on CVS, which indicates an upside potential of 15.0% based on its closing price of $77.90 on November 6.
Market Realist•7 days agoWhat Drove CVS Health’s Bottom Line in Q3 2018?
CVS Health (CVS) maintained its streak of exceeding Wall Street analysts’ bottom-line expectation during the third quarter. CVS posted adjusted earnings of $1.73, which beat analysts’ estimate of $1.71 and increased 15.3% on a YoY (year-over-year) basis. The following graph shows that CVS has reported better-than-expected earnings for five consecutive quarters.
Market Realist•7 days agoCVS’s Q3 Sales Beat the Estimate
CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion, which beat analysts’ estimate of $47.2 billion and increased 2.4% on a YoY (year-over-year) basis. Increased net new business, the growing adoption of Maintenance Choice offerings, brand inflation, and higher same-store prescription volumes drove the company’s third-quarter net sales growth.
- PR Newswire•7 days ago
MinuteClinic Opens First Walk-in Medical Clinic in San Francisco
WOONSOCKET, R.I., Nov. 7, 2018 /PRNewswire/ -- A new MinuteClinic walk-in medical clinic has opened inside the CVS Pharmacy store at 1900 19th Avenue in San Francisco, California, providing the community with convenient access to common health care services. The clinic is the first MinuteClinic location in the city of San Francisco and will be open seven days a week with no appointment necessary. MinuteClinic is the retail medical clinic of CVS Health (CVS), the largest pharmacy health care provider in the United States.
Market Realist•7 days agoCVS Stock Rose 5.7% Due to Strong Third-Quarter Results
CVS Health (CVS) reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates due to the strong comp script growth, higher drug prices, and growth in claim volumes. However, pricing and reimbursement pressure remained a drag.
Markit•7 days agoSee what the IHS Markit Score report has to say about CVS Health Corp.
CVS Health Corp NYSE:CVS
- ACCESSWIRE•7 days ago
Today's Research Reports on Trending Tickers: CVS Health and Aetna
NEW YORK, NY / ACCESSWIRE / November 7, 2018 / U.S. stocks closed in the green on Tuesday, with the Dow Jones rallying 173 points, as investors braced for the midterm election results. The Dow Jones Industrial ...
- Reuters•7 days ago
US STOCKS-S&P 500 futures up as Democrats capture U.S. House
U.S. stock futures held onto gains on Tuesday after media projections showed the Democrats winning control of the House of Representatives in U.S. midterm congressional elections. With President Donald Trump's Republican party holding onto their majority in the Senate, according to CNN, NBC and ABC News, the results were in line with expectations on Wall Street that Washington was set for gridlock.
Associated Press•7 days agoAsian markets rise pending US midterm election results
TOKYO (AP) — Asian shares were mostly higher Wednesday as investors awaited results from the U.S. midterm elections, which could have an impact on the global economy and trade.
Associated Press•7 days agoMarkets Right Now: Asian shares rise pending US vote results
NEW YORK (AP) — The latest on developments in financial markets (all times local):
- Motley Fool•7 days ago
Why CVS Health Stock Jumped Today
Investors liked what they saw with the pharmacy giant's Q3 earnings update.
- Reuters•7 days ago
US STOCKS-Wall St gains as investors look to U.S. elections
Wall Street's major indexes closed higher on Tuesday as voters headed to the polls in U.S. midterm congressional elections and investors hoped the result would provide some relief for stocks after prolonged uncertainty. Some stocks such as CVS Health Corp and Mylan NV were boosted by strong earnings, but despite a late afternoon spike in buying, trading volume was relatively thin as many investors held back on making big bets in case of a surprise election outcome. Wall Street had been expecting that President Donald Trump's Republican party would lose control of the House of Representatives, while retaining the Senate.
